Validation of Lung Ultrasound for Early Diagnosis of Ventilator Associated Pneumonia in ICU
Authors/Creators
- 1. Fellowship Emergency Critical Care, Department of Trauma and Emergency, Igims, Patna, Bihar, India
- 2. Assistant Professor, Department of Trauma and Emergency, Igims, Patna, Bihar, India
- 3. Associate Professor, Department of Critical Care medicine, Igims, Patna, Bihar, India
Description
Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections in critically ill patients which are often reported to be associated with morbidity, mortality, long duration of ICU stay, and mechanical ventilation (MV). Due to the lack of validated gold standard diagnostic test for VAP detection, delay in patient treatment results in increased patient mortality. A total of 40 patients were included in the study. Of the 40 patients, 28 patients had mini-BAL culture-confirmed VAP that was considered the gold standard for VAP diagnosis while 12 patients did not have mini-BAL culture confirmed VAP. The CXR, microbiological culture, CPIS and LUS score were recorded and compared from the Day 1 to Day 7 till the discharge of the patients. The mean lymphocyte and platelet count among the patients with mini-BAL culture-proven VAP was found to be higher in comparison to those without mini-BAL culture-proven VAP. The mean SOFA and APACHE score was also found to be significantly higher among the patients with mini-BAL culture-proven VAP. There was a significant decrease in the mean LUS score and CPIS score for the patients from Day 1 till the day of the discharge of the patients. The study concludes that the LUS score and the CPIS score are good diagnostic marker for the detection of VAP which can be utilized for clinical decision making of patients admitted in hospital with suspected VAP.
Abstract (English)
Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections in critically ill patients which are often reported to be associated with morbidity, mortality, long duration of ICU stay, and mechanical ventilation (MV). Due to the lack of validated gold standard diagnostic test for VAP detection, delay in patient treatment results in increased patient mortality. A total of 40 patients were included in the study. Of the 40 patients, 28 patients had mini-BAL culture-confirmed VAP that was considered the gold standard for VAP diagnosis while 12 patients did not have mini-BAL culture confirmed VAP. The CXR, microbiological culture, CPIS and LUS score were recorded and compared from the Day 1 to Day 7 till the discharge of the patients. The mean lymphocyte and platelet count among the patients with mini-BAL culture-proven VAP was found to be higher in comparison to those without mini-BAL culture-proven VAP. The mean SOFA and APACHE score was also found to be significantly higher among the patients with mini-BAL culture-proven VAP. There was a significant decrease in the mean LUS score and CPIS score for the patients from Day 1 till the day of the discharge of the patients. The study concludes that the LUS score and the CPIS score are good diagnostic marker for the detection of VAP which can be utilized for clinical decision making of patients admitted in hospital with suspected VAP.
Files
IJPCR,Vol14,Issue8,Article13.pdf
Files
(460.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:b950e7e576a9f17543fdb602d1324f1d
|
460.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-07-23
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue8,Article13.pdf
- Development Status
- Active
References
- 1. Fartoukh, M., Maître, B., Honoré, S., Cerf, C., Zahar, J.-R., & Brun-Buisson, C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. American journal of respiratory and critical care medicine, 2003:168(2), 173-179. 2. Heyland, D. K., Cook, D. J., Griffith, L., Keenan, S. P., & BrunBuisson, C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. American journal of respiratory and critical care medicine, 1999:159(4), 1249-1256. 3. Vincent, J.-L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Chanoin, M.-H., . . . Hemmer, M. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. Jama, 1995:274(8), 639-644. 4. Sperandeo M., Carnevale V., Muscarella S., Sperandeo, G., Varriale A., Filabozzi P., Pellegrini F. Clinical application of transthoracic ultrasonography in inpatients with pneumonia. European journal of clinical investigation, 2011:41(1), 1-7. 5. Lichtenstein, D. R., Drumwright, M. E., & Braig, B. M. The effect of corporate social responsibility on customer donations to corporatesupported nonprofits. Journal of marketing, 2004:68(4), 16-32.6. Victor, L. Y., & Singh, N. Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia. Intensive care medicine, 2004:30(5), 735-738. 7. Society, A. T., & America, I. D. S. O. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. American journal of respiratory and critical care medicine, 2005:171(4), 388. 8. Rello, J., Ausina, V., Ricart, M., Puzo, C., Quintana, E., Net, A., & Prats, G. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive care medicine, 1994:20(3), 193-198. 9. Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest, 2000:118(1), 146-155. 10. Trouillet, J.-L., Chastre, J., Vuagnat, A., Joly-Guillou, M.-L., Combaux, D., Dombret, M.-C., & Gibert, C. Ventilator-associated pneumonia caused by potentially drug- resistant bacteria. American journal of respiratory and critical care medicine, 1998:157(2), 531-539. 11. Luna, C. M., Blanzaco D., Niederman M. S., Matarucco W., Baredes N. C., Desmery P. Apezteguia, C. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Critical care medicine, 2003:31(3), 676-682. 12. Dellinger R. P., Levy M. M., Carlet J. M., Bion J., Parker M. M., Jaeschke, R., Beale R. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive care medicine, 2008:34(1), 17-60. 13. Pugin, J., Auckenthaler, R., Mili, N., Janssens, J.-P., Lew, P. D., & Suter, P. M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. American Review of Respiratory Disease, 1991:143(5_pt_1), 1121- 1129. 14. Croce M. A., Swanson J. M., Magnotti L. J., Claridge J. A., Weinberg J. A., Wood, G. C., Fabian, T. C. The futility of the clinical pulmonary infection score in trauma patients. Journal of Trauma and Acute Care Surgery, 2006:60(3), 523-528. 15. Schurink, C. A., Van Nieuwenhoven C. A., Jacobs J. A., Rozenberg-Arska, M., Joore H. C., Buskens, E., Bonten M. J. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and interobserver variability. Intensive care medicine, 2004:30(2), 217-22 4. 16. Inglis A. J., Nalos M., Sue K.-H., Hruby J., Campbell D. M., Braham R. M., & Orde, S. R. Bedside lung ultrasound, mobile radiography and physical examination: a comparative analysis of diagnostic tools in the critically ill. Critical Care and Resuscitation, 2016:18(2), 116-124. 17. Marsh, R., & Itinteang, T. Treatment of cancers with a novel combination of re-purposed pharmaceuticals and nutriceuticals. Clinical Medicine Insights, 2022:3(3), 318–321. 18. Hu Q.-J., Shen Y.-C., Jia L.-Q., Guo S.-J., Long H.-Y., Pang C.-S., Wen, F.- Q. Diagnostic performance of lung ultrasound in the diagnosis of pneumonia: a bivariate meta-analysis. International journal of clinical and experimental medicine, 2014:7(1), 115.